EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Building a Fast Response Capability for Emerging Infectious Diseases Within the Biomedical Advanced Research and Development Authority

Robert A Johnson, Terence M Barnhart iD, Gary L Disbrow

Health Security · 2025

DOI: 10.1089/hs.2024.0074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Security, 2025. Verfasst von Robert A Johnson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Robert A. Johnson, PhD, is Director, Medical Countermeasures Programs, and Gary L. Disbrow, PhD, is Director, Center for Biomedical Advanced Research…. Hauptthemen laut MEDLINE: Communicable Diseases, Emerging, Biomedical Research, Medical Countermeasures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

From influenza to COVID-19, emerging infectious diseases have taken a heavy toll on lives and resources. Emerging infectious diseases represent one of the largest threats to national security. The primary mission of the Center for Biomedical Advanced Research and Development Authority (BARDA), within the US Administration for Strategic Preparedness and Response, is to support the advanced development of medical countermeasures (MCMs) for public health security threats, including select infectious diseases. Given the number of potential emerging infectious diseases, it is not feasible to develop a suite of MCMs necessary for a full response, including vaccines, therapeutics, and diagnostics. In this article, the authors describe BARDA’s 3-step strategy to address emerging infectious diseases: (1) prioritize the development of MCMs for BARDA’s priority pathogens with an increased focus on “platform technologies” with rapid development capabilities; (2) develop response capabilities including specific licensed medical countermeasures and flexible, rapid MCM development infrastructure; and (3) improve those response capabilities, so they are finely tuned and ready when needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Communicable Diseases, EmergingBiomedical ResearchMedical CountermeasuresHumansUnited StatesCOVID-19SARS-CoV-2

Stichwörter der Autor:innen

Biodefense R&DCountermeasuresEmerging infectious diseasesEpidemic management/responseInfectious diseasesNational strategy/policy

Autor:innen und Institutionen

  • Robert A. Johnson, PhD, is Director, Medical Countermeasures Programs, and Gary L. Disbrow, PhD, is Director, Center for Biomedical Advanced Research and Development Authority (BARDA), Washington, DC. Terence M. Barnhar…

ORCID-Profile: Terence M Barnhart

Zitieren

APA

Johnson, R. A., Barnhart, T. M., & Disbrow, G. L. (2025). Building a Fast Response Capability for Emerging Infectious Diseases Within the Biomedical Advanced Research and Development Authority. Health Security. https://doi.org/10.1089/hs.2024.0074

Vancouver

Johnson RA, Barnhart TM, Disbrow GL. Building a Fast Response Capability for Emerging Infectious Diseases Within the Biomedical Advanced Research and Development Authority. Health Security. 2025. doi:10.1089/hs.2024.0074

BibTeX
@article{Johnson2025,
  author = {Johnson, Robert A and Barnhart, Terence M and Disbrow, Gary L},
  title = {Building a Fast Response Capability for Emerging Infectious Diseases Within the Biomedical Advanced Research and Development Authority},
  journal = {Health Security},
  year = {2025},
  doi = {10.1089/hs.2024.0074}
}
Kostenlos starten →